Advanced Genetic Systems Inc - Company Review
Advanced Genetic Systems Inc - Company ReviewSummary
Advanced Genetic Systems Inc (AGS) is a drug discovery company that develops antiviral therapeutics. The company utilizes its cell based screening platform to target Ribonucleoprotein (RNP) complex, a combination of interactions between structural RNA and proteins. Its technology addresses the dynamic conformations, multiple roles and chemical instability of these complexes. AGS also develops novel chemical strategies such as the screening and assembly of custom libraries designed to the chemistry of RNPs. The company develops therapeutics for human immunodeficiency virus type 1 (HIV-1) that causes acquired immune deficiency syndrome (AIDS). AGS is headquartered in San Francisco, California, the US.
This comprehensive company report of Advanced Genetic Systems Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.